| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Gathagan Bryan K. serves as a Director at ICCC. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $6K at current prices.
The biggest single holding is ICCC (~$6K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 1,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | ICCC Immucell Corp /de/ | Director | Buy | 1,000 | $6.32 | $6,320.00 | New | -3.9% | - |